William Garrett Nichols - Sep 12, 2022 Form 4 Insider Report for Candel Therapeutics, Inc. (CADL)

Role
Chief Medical Officer
Signature
/s/ John Canepa, as Attorney-In-Fact for William Garrett Nichols
Stock symbol
CADL
Transactions as of
Sep 12, 2022
Transactions value $
$0
Form type
4
Date filed
9/14/2022, 05:05 PM
Next filing
Nov 30, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CADL Stock Option (Right to Buy) Award $0 +200K $0.00 200K Sep 12, 2022 Common Stock 200K $3.75 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The first 100,000 shares underlying this option shall vest as follows: 25% shall vest and become exercisable on September 12, 2023, with the remainder vesting in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date. The remaining 100,000 shares underlying this option shall vest as follows: 25% shall vest and become exercisable on the first anniversary of the date in which the Reporting Person converts to a full-time employee, with the remainder vesting in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.